Ameriprise
PLRX icon

Ameriprise’s Pliant Therapeutics PLRX Stock Holding History

Ameriprise’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$69.5K Buy
+55,129
New +$69.6K ﹤0.01% 3989
2024
Q2 		– Sell
-371,126
Closed -$5.53M – 3922
2024
Q1 		$5.53M Buy
371,126
+1,325
+0.4% +$21.9K ﹤0.01% 2298
2023
Q4 		$6.7M Sell
369,801
-2,326
-0.6% -$35.4K ﹤0.01% 2123
2023
Q3 		$6.45M Buy
+372,127
New +$6.45M ﹤0.01% 2087

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Ameriprise's PLRX Position: Q1 2026 in Review

Ameriprise opened a new position in Pliant Therapeutics (PLRX) in Q1 2026: 55,129 shares worth $69.5K. The stake represents ﹤0.01% of the portfolio and ranks #3989 among its holdings. This is a return to the name: Ameriprise previously reported a position in PLRX as recently as Q1 2024.

Ameriprise first reported a position in PLRX in Q3 2023 and has held it in 4 quarters since. The position peaked at $6.7M in Q4 2023. 91 funds tracked by Wall St. Rank hold PLRX as of Q1 2026.

  • Ameriprise held 55,129 shares of Pliant Therapeutics worth $69.5K as of Q1 2026.
  • Pliant Therapeutics was a new Ameriprise position in Q1 2026.
  • Pliant Therapeutics made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #3989 holding.
  • Ameriprise first reported a position in Pliant Therapeutics in Q3 2023 and has held it in 4 quarters since.
  • Ameriprise's Pliant Therapeutics position peaked at $6.7M in Q4 2023.
  • 91 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.